The chemical chaperone 4-phenylbutyric acid rescues molecular cell defects of COL3A1 mutations that cause vascular Ehlers Danlos SyndromeRamla Omar(University of Glasgow), Tom Van Agtmael(University of Glasgow)Cell Death DiscoveryApril 25, 202510.1038/s41420-025-02476-yCited by 8SaveCiteExport RISWatch citationsRelated PapersChemical chaperone treatment reduces intracellular accumulation of mutant collagen IV and ameliorates the cellular phenotype of a COL4A2 mutation that causes haemorrhagic stroke|Human Molecular Genetics|2013|79